RE: Attogene to expand SARS-CoV-2 variants testing in the United States11 May 2021 08:30
Morning all
Great article Ad to lead to a change of direction
Lance P. Ford, PhD, President and CEO of Attogene Corporation said: “We are pleased to be able to provide Novacyt’s state of the art assays to ensure that the country has cutting edge detection tests to better monitor SARS-CoV-2 variants. We look forward to the opportunity of expanding our support of variant testing in the U.S. through our established infrastructure.”